BioCentury | May 15, 2008
Distillery Therapeutics

This Week in Therapeutics

...by Louis Pasteur University and the Centre National de la Recherche Scientifique (CNRS); licensed by NexGenix Pharmaceuticals Inc....
BioCentury | Mar 3, 2008
Clinical News

NexGenix preclinical data

...kidney toxicity. Data were presented at GTCBio's Cancer Drugs Research & Development meeting in Phoenix. NexGenix Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Company News

NexGenix, Universite Louis Pasteur, Centre National de la Recherche Scientifique deal

...institutions will receive undisclosed upfront payments and are eligible for maintenance fees, milestones and royalties. NexGenix...
...also will collaborate to study pharmacokinetic properties of the compounds. Further terms were not disclosed. NexGenix Pharmaceuticals Inc....
BioCentury | Oct 2, 2006
Company News

NexGenix management update

NexGenix Pharmaceuticals Inc. , New York, N.Y. Business: Cancer Hired: Donald Cilla Jr. as VP of clinical development and COO, formerly executive director of clinical pharmacology and clinical operations at Par Pharmaceuticals Cos. Inc.; he replaces...
Items per page:
1 - 4 of 4
BioCentury | May 15, 2008
Distillery Therapeutics

This Week in Therapeutics

...by Louis Pasteur University and the Centre National de la Recherche Scientifique (CNRS); licensed by NexGenix Pharmaceuticals Inc....
BioCentury | Mar 3, 2008
Clinical News

NexGenix preclinical data

...kidney toxicity. Data were presented at GTCBio's Cancer Drugs Research & Development meeting in Phoenix. NexGenix Pharmaceuticals Inc....
BioCentury | Oct 1, 2007
Company News

NexGenix, Universite Louis Pasteur, Centre National de la Recherche Scientifique deal

...institutions will receive undisclosed upfront payments and are eligible for maintenance fees, milestones and royalties. NexGenix...
...also will collaborate to study pharmacokinetic properties of the compounds. Further terms were not disclosed. NexGenix Pharmaceuticals Inc....
BioCentury | Oct 2, 2006
Company News

NexGenix management update

NexGenix Pharmaceuticals Inc. , New York, N.Y. Business: Cancer Hired: Donald Cilla Jr. as VP of clinical development and COO, formerly executive director of clinical pharmacology and clinical operations at Par Pharmaceuticals Cos. Inc.; he replaces...
Items per page:
1 - 4 of 4